Two FDA approvals, smoking impacts CV health for 25 years

MDedge Cardiocast

内容由MDedge提供。所有播客内容（包括剧集、图形和播客描述）均由 MDedge 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

5+ y ago 8:19

TAVR valves now FDA approved for low-risk patients The FDA's decision will expand TAVR access to younger, healthier patients.
FDA approves baroreflex activation for advanced HF A phase 4 trial will investigate impact on hospitalizations and mortality.
Top line results: Dapagliflozin meets primary endpiont in DAPA-HF AstraZeneca announces preliminary results in first heart failure trial in an SGLT2 inhibitor.
Cardiovascular cost of smoking may last up to 25 years Past smokers face an elevated cardiovascular risk for up to 25 years.

You can contact the MDedge Cardiocast by emailing us at podcasts@mdedge.com or following us on Twitter at @MDedgeTweets.

87集单集

50 subscribers

published 5+ y ago

TAVR valves now FDA approved for low-risk patients The FDA's decision will expand TAVR access to younger, healthier patients.
FDA approves baroreflex activation for advanced HF A phase 4 trial will investigate impact on hospitalizations and mortality.
Top line results: Dapagliflozin meets primary endpiont in DAPA-HF AstraZeneca announces preliminary results in first heart failure trial in an SGLT2 inhibitor.
Cardiovascular cost of smoking may last up to 25 years Past smokers face an elevated cardiovascular risk for up to 25 years.

You can contact the MDedge Cardiocast by emailing us at podcasts@mdedge.com or following us on Twitter at @MDedgeTweets.

87集单集

Player FM正在网上搜索高质量的播客，以便您现在享受。它是最好的播客应用程序，适用于安卓、iPhone和网络。注册以跨设备同步订阅。